|
...Senate seat, an aide to the Source: abcnews.go.com FDA Clears Geron to Begin Clinical Testing of hESC Product - Genetic Engineering News The FDA is allowing Geron to initiate a Phase I trial using its human embryonic stem cell (hESC) product, GRNOPC1, in patients with acute spinal cord injury. The decision lifts a clinical hold on the treatment,...

http://dshampoo-sx.livejournal.com/69558.html
(Cached)
0 links
Published: 5 months, 3 weeks ago (Fri, 23 Jan 2009 09:42:52 PST); 3379 bytes
|